Ligand ID: LQZ Drugbank ID: DB00281(Lidocaine) Indication:For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | PRO A 241THR A 243LEU A 227 | 1.55A | 23.82 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6m0j | SPIKE RECEPTORBINDING DOMAIN (SARS-CoV-2) | 3 / 3 | PRO E 521THR E 393LEU E 518 | 1.43A | 21.68 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | PRO A 241THR A 243LEU A 227 | 1.54A | 23.76 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 3 / 3 | PRO A 241THR A 243LEU A 227 | 1.54A | 23.63 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 3 / 3 | PRO B 241THR B 243LEU B 227 | 1.55A | 23.63 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | PRO B 169THR B 167LEU A 105 | 1.41A | 17.68 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 461THR A 462LEU A 247 | 1.28A | 15.47 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 461THR A 319LEU A 316 | 1.60A | 15.47 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | PRO B 491THR B 470LEU B 452 | 1.23A | 14.40 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | PRO C 600THR C 599LEU C 296 | 1.42A | 14.00 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 3 / 3 | PRO C 521THR C 393LEU C 518 | 1.59A | 19.70 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | PRO A6860THR A7055LEU A7078 | 1.71A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | PRO A 241THR A 243LEU A 227 | 1.52A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | PRO C6860THR C7055LEU C7078 | 1.70A | 18.84 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | PRO A6860THR A7055LEU A7078 | 1.70A | 18.84 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | PRO C6860THR C7055LEU C7078 | 1.70A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | PRO A6860THR A7055LEU A7078 | 1.69A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | PRO C6860THR C7055LEU C7078 | 1.70A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | PRO A6860THR A7055LEU A7078 | 1.70A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | PRO A6860THR A7055LEU A7078 | 1.68A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6xez | NSP12NSP8 (SARS-CoV-2) | 3 / 3 | PRO B 121THR B 123LEU A 270 | 1.39A | 21.57 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6xez | NSP13 (SARS-CoV-2) | 3 / 3 | PRO F 254THR F 255LEU F 297 | 1.04A | 20.26 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6xez | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 830THR A 817LEU A 602 | 1.02A | 15.73 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6xez | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 461THR A 462LEU A 247 | 1.28A | 15.73 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 6xez | NSP13 (SARS-CoV-2) | 3 / 3 | PRO F 434THR F 279LEU F 428 | 0.93A | 20.26 | None | ||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7btf | NSP12NSP8 (SARS-CoV-2) | 3 / 3 | PRO B 121THR B 123LEU A 270 | 1.54A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 461THR A 462LEU A 247 | 1.35A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 830THR A 817LEU A 602 | 1.13A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 461THR A 319LEU A 316 | 1.54A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7btf | NSP8 (SARS-CoV-2) | 3 / 3 | PRO B 121THR B 124LEU B 98 | 1.42A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 830THR A 817LEU A 602 | 1.15A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 461THR A 462LEU A 247 | 1.31A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 461THR A 319LEU A 316 | 1.64A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 323THR A 324LEU A 270 | 1.75A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 461THR A 462LEU A 247 | 1.36A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 830THR A 817LEU A 602 | 1.18A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 3 / 3 | PRO B 121THR B 123LEU A 270 | 1.45A | None | |||
![]() | 3TTR_A_LQZA90_1 (LACTOTRANSFERRIN) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | PRO A 323THR A 324LEU A 270 | 1.78A | None |